H1 2025 revenue of top multinational pharma companies
We’ve just wrapped up Q2 earnings season, and here’s a look at the revenues pharma generated during the first half of the year.
These are the revenues:
1. Johnson & Johnson - $29.08B
2. AbbVie - $28.77B
3. Pfizer - $28.37B
4. Eli Lilly and Company - $28.29B
5. AstraZeneca - $28.05B
6. Merck - $27.69B
7. Novartis - $27.29B
8. Roche - $26.62B
9. Bristol Myers Squibb - $23.47B
10. Novo Nordisk - $23.24B
11. Sanofi - $21.68B
12. GSK - $19.84B
13. Amgen - $17.33B
Read also: Top Selling Medicines in 2025
